Matthew Brams - Net Worth and Insider Trading
Matthew Brams Net Worth
The estimated net worth of Matthew Brams is at least $23,652 dollars as of 2026-09-11. Matthew Brams is the EVP and Chief Medical Officer of Cingulate Inc and owns about 4,656 shares of Cingulate Inc (CING) stock worth over $23,652. Details can be seen in Matthew Brams's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew Brams has not made any transactions after 2026-02-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Matthew Brams
Matthew Brams Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew Brams owns 1 companies in total, including Cingulate Inc (CING) .
Click here to see the complete history of Matthew Brams’s form 4 insider trades.
Insider Ownership Summary of Matthew Brams
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| CING | Cingulate Inc | 2026-02-06 | EVP & Chief Medical Officer |
Matthew Brams Latest Holdings Summary
Matthew Brams currently owns a total of 1 stock. Matthew Brams owns 4,656 shares of Cingulate Inc (CING) as of February 6, 2026, with a value of $23,652.
Latest Holdings of Matthew Brams
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CING | Cingulate Inc | 2026-02-06 | 4,656 | 5.08 | 23,652 |
Holding Weightings of Matthew Brams
Matthew Brams Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew Brams has made a total of 1 transactions in Cingulate Inc (CING) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cingulate Inc is the acquisition of 1,946 shares on February 6, 2026, which cost Matthew Brams around $9,808.
Insider Trading History of Matthew Brams
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Matthew Brams Trading Performance
GuruFocus tracks the stock performance after each of Matthew Brams's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Matthew Brams is -30.78%. GuruFocus also compares Matthew Brams's trading performance to market benchmark return within the same time period. The performance of stocks bought by Matthew Brams within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Matthew Brams's insider trading performs compared to the benchmark.
Performance of Matthew Brams
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -16.49 |  | | | | |
| Relative Return to S&P 500(%) | -13.72 | | | | | |
Matthew Brams Ownership Network
Ownership Network List of Matthew Brams
Ownership Network Relation of Matthew Brams
Matthew Brams Owned Company Details
What does Cingulate Inc do?
Who are the key executives at Cingulate Inc?
Matthew Brams is the EVP & Chief Medical Officer of Cingulate Inc. Other key executives at Cingulate Inc include director & 10 percent owner & Chief Executive Officer Shane J. Schaffer , director & 10 percent owner Peter J. Werth , and Corporate Controller Jennifer L. Callahan .
Cingulate Inc (CING) Insider Trades Summary
Over the past 18 months, Matthew Brams made 1 insider transaction in Cingulate Inc (CING) with a net purchase of 1,946. Other recent insider transactions involving Cingulate Inc (CING) include a net purchase of 97,276 shares made by Thomas Jeffrey Hargroves , a net purchase of 19,455 shares made by Peter J. Werth , and a net purchase of 6,809 shares made by Shane J. Schaffer .
In summary, during the past 3 months, insiders sold 0 shares of Cingulate Inc (CING) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cingulate Inc (CING) were sold and 130,350 shares were bought by its insiders, resulting in a net purchase of 130,350 shares.
Cingulate Inc (CING)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cingulate Inc Insider Transactions
Matthew Brams Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew Brams. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Matthew Brams's mailing address is: Kansas City Ks 66205.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
